Lindsay Olson, PA-C | |
3316 Us-280, Alexander City, AL 35010 | |
(256) 329-7100 | |
Not Available |
Full Name | Lindsay Olson |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 3316 Us-280, Alexander City, Alabama |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548932544 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0127X | Surgery - Trauma Surgery | 54866 (Ohio) | Secondary |
207XX0005X | Orthopaedic Surgery - Sports Medicine | 2008 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lindsay Olson, PA-C 825 Still Waters Dr, Dadeville, AL 36853-4986 Ph: (702) 757-8294 | Lindsay Olson, PA-C 3316 Us-280, Alexander City, AL 35010 Ph: (256) 329-7100 |
News Archive
Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center (BUMC) have found that tandem cycles of high-dose chemotherapy and blood stem cell transplantation can help treat patients with immunoglobulin-light chain (AL) Amyloidosis who did not respond to initial treatment with this method.
Emphasizing its commitment to low-dose medical imaging, GE Healthcare today announced 510(k) clearance of its revolutionary Computed Tomography (CT) technology, called Veo,* which may help physicians deliver accurate diagnoses by enabling profound CT image clarity at dramatically lower dose. Veo represents the CT industry's first Model-based Iterative Reconstruction (MBIR) technique, and is already available on GE Discovery CT750 HD systems in Europe, Canada and regions of Asia.
A prospective study of patients admitted to a children's hospital in Italy identified risk factors for falls. It found that lack of attention among parents or caregivers, or by the children, accounted for 41 per cent of falls and that most falls occurred when a parent or caregiver was present, indicating that such supervision did not necessarily prevent a fall.
FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, based at RCSI, has partnered with global biopharmaceutical company, UCB, to unlock the power of healthcare data to inform improvements in clinical care of people with epilepsy.
Researchers have uncovered mutations in the phosphatase Wip1 that enable cancer cells to foil the tumor suppressor p53, according to a study in The Journal of Cell Biology. The results could provide a new target for the treatment of certain cancers.
› Verified 9 days ago
Mr. Graham Lee Howorth Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1120 Airport Drive, Ste 101, Alexander City, AL 35010 Phone: 256-234-0989 Fax: 256-234-3114 |